Publications - Dr. Judith R. Davidson
Publications


JOURNAL ARTICLES

Moldofsky H, Tullis C, Lue FA, Quance G, and Davidson J. 1984. Sleep related myoclonus in Rheumatic Pain Modulation Disorder (Fibrositis syndrome) and in excessive daytime somnolence. Psychosomatic Medicine 46(2):145 151.

Moldofsky H, Lue FA, Davidson JR and Gorczynski R. 1989. Effects of sleep deprivation on human immune functions. FASEB J 3:1972 1977.

Moldofsky H, Lue FA, Davidson JR, Jephthah-Ochola J, Carayanniotis K and Gorczynski R. 1989. The effect of 64 hurs of wakefulness on immune functions and plasma cortisol in humans. In: Sleep ‘88, J. Horne (Ed.) pp.185-187. Gustav Fischer Verlag: New York

Davidson JR, Moldofsky H and Lue FA. 1991. Growth hormone and cortisol secretion in relation to sleep and wakefulness. J Psychiatr Neurosci 16(2):96 102.

O'Connor HM and Davidson JR. 1992. Emergency Medicine Skills: Are primary care physicians adequately prepared? Can Family Physician 38:1789-1793.

Brison RJ, Davidson JR, Dreyer JF, Jones G, Maloney J, Munkley DP, O'Connor HM and Rowe BH. 1992. Cardiac arrest in Ontario: circumstances, community response, role of prehospital defibrillation and predictors of survival. Can Med Assoc J 147(2):191-9.

Pickett W, Davidson JR and Brison RJ. 1993. Suicides on Ontario farms. Can J Public Health 84(4):226-230.

Verma S, Quirt IC, Eisenhauer EA, Iscoe NA, Young VJ, Bodurtha AJ and Davidson JR. 1993. A phase II study of weekly edatrexate (10-EDAM) in metastatic melanoma. A National Cancer Institute of Canada Clinical Trials Group Study. Annals of Oncology 4:254-255.

Maroun JA, Skillings J, MacCormick R, Potvin M, Wielgosz G, Davidson JR and Eisenhauer E. 1993. Phase II Study of DuP 937 (Teloxantrone) in colorectal carcinoma. Invest New Drugs 11:235-237.

Brundage MD, Davidson JR, and Mackillop WJ. 1997. Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. Journal of Clinical Oncology 15:330-340.

Brundage MD, Groome PA, Feldman-Stewart D, Davidson JR and Mackillop, WJ. 1997. Decision analysis in locally advanced non-small cell lung cancer - Is it useful? Journal of Clinical Oncology 15:873-883.

Feldman-Stewart D, Brundage MD, Hayter C, Davidson JR, Groome P and Nickel JC. 1997. What the prostate cancer patient should know: Variation in urologists’ opinions. Canadian Journal of Urology 4:438-444.

Brundage MD, Davidson JR, Mackillop WJ, Feldman-Stewart D and Groome P. 1998. Using a treatment trade-off method to elicit preferences for the treatment of locally advanced non-small cell lung cancer. Medical Decision Making 18:256-267.
4:08:07 PM 15/06/2005

Davidson JR, Brundage MD and Feldman-Stewart D. 1999. Lung cancer treatment decisions: Patients' desires for participation and information. Psycho-Oncology 8:511-520.

Davidson JR, Waisberg JL, Brundage MD and MacLean AW. 2001. Nonpharmacologic group treatment of insomnia: A preliminary study with cancer survivors. Psycho-Oncology 10:389-397.

Davidson JR, MacLean AW, Brundage MD and Schulze K. 2002. Sleep disturbance in cancer patients. Social Science and Medicine 54(9):1309-1321.

Savard J, Davidson JR, Ivers H, Quesnel C, Rioux D, Dupéré V, Lasnier M, and Simard S. 2004. The association between nocturnal hot flashes and sleep in breast cancer survivors with insomnia. Journal of Pain and Symptom Management, 27: 513-522.

Davidson JR, Aime A, Ivers H, and Morin CM. 2004. Characteristics of Individuals with insomnia who seek treatment in a clinical setting versus those who volunteer for a research study. Sleep, 27: A265 (#594).


BOOK CHAPTERS

Morin, CM, Davidson JR and Savard J. Behavioral Treatment of Insomnia. 2005. In M. Hersen (Ed.) Encyclopedia of Behavior Modification and Therapy. Volume 1, pp. 160-164.Thousand Oaks, CA: Sage Publications.


SPECIAL REPORTS

Davidson JR and Arnedt JT. December 1996. Sleep Disorders and Risk of Automobile Crash. Report for the subcommittee on Accident Prevention, Ontario Medical Association.

top of page

ABSTRACTS

Davidson JR, Radomski MW, Heslegrave RJ, Angus RG, and Montelpare WmJ. 1986. Sleep structure of a nap following 40 hours of sleep deprivation and its relation to performance upon awakening. Sleep Research 15:213.

Davidson JR, Pigeau RA, Angus RG, and Radomski MW. 1987. Relation of subjective state to performance during sleep deprivation. Sleep Research 16:517.

Moldofsky H, Lue FA, Davidson JR, Jephthah Ochola J, Carayanniotis K, Saskin P and Gorczynski R. 1987. Sleep deprivation and plasma IL 1 activity in man. J. Leukocyte Biology 42(5):602.

Moldofsky H, Lue FA, Saskin P, Davidson JR, and Gorczynski R. 1987. The effect of sleep deprivation on immune functions in human I. Mitogen and Natural Killer cell activities. Sleep Research 16:531.

Moldofsky H, Lue FA, Davidson JR, and Gorczynski R. 1988. The effect of 40 hours of wakefulness on immune functions in humans II. Interleukins 1 and 2 like activities. Sleep Research 17:24.

Moldofsky H, Davidson JR, and Lue FA. 1988. Sleep related patterns of plasma growth hormone and cortisol following 40 hours of wakefulness. Sleep Research 17:69.

Moldofsky H, Lue FA, Davidson JR, and Gorczynski R. 1988. Disordered diurnal patterns of immune functions in three patients with narcolepsy cataplexy. Sleep Research 17:223.

Moldofsky H, Lue FA, Davidson JR, Saskin P, Gorczynski R. 1989. Comparison of sleep wake circadian immune functions in women versus men. Sleep Research 18:431.

Davidson JR and the Ontario Prehospital Care Study Group. 1991. Circadian variation in the incidence of cardiac arrest. Sleep Research 20:370.

Maroun JA, Skillings J, MacCormick R, Potvin M, Davidson J, Eisenhauer E. 1992. Phase II study of DuP-937 in colorectal carcinoma. A Canadian National Cancer Institute Clinical Trials Groups (NCIC CTG) study. Proc Am Soc Clin Oncol, San Diego, Ca. Abstract #532.

Brundage MD and Davidson JR. 1994. Trading treatment toxicity for survival in locally advanced lung cancer. J Clin Invest Med 17(4) Abstract # 696. The Royal College of Physicians and Surgeons of Canada Annual Meeting (CARO), Toronto.

Brundage MD and Davidson JR. 1994. Treatment decision making in locally advanced lung cancer: What information do people need? J Clin Invest Med 17(4) Abstract # 694. The Royal College of Physicians and Surgeons of Canada Annual Meeting (CARO), Toronto.

Brundage MD and Davidson JR. 1995. What survival advantage justifies combined chemotherapy and radiation therapy for locally advanced non-small cell lung cancer? Proc Am Soc Clin Oncol.

Brundage MD, Feldman-Stewart D, Groome PA and Davidson JR. 1995 Assessing the reliability of a treatment trade-off instrument: An index of consistency of patient preference. Med Decis Making 15(4):427. Meeting of the Society for Medical Decision Making, Tempe, Arizona.

Feldman-Stewart D, Brundage MD, Hayter C, Groome P, Davidson JR and Nickel J. 1996. Professionals' opinions about questions to address with curable prosate cancer patients. Med Decis Making 16(4):448. Society for Medical Decision Making.

Brundage MD, Davidson JR and Mackillop WJ. 1996 . Patients' preferred roles in treatment decisions: Do they relate to information and treatment preferences? J Clin Invest Med 19(Suppl) Abstract # 583. The Royal College of Physicians and Surgeons of Canada Annual Meeting (CARO), Halifax, Nova Scotia.

Brundage MD, Davidson JR and Feldman-Stewart D 1996. Shared decision making in clinical practice: Who needs it? European Society for Psychosocial Oncology, Amsterdam.

Feldman-Stewart D, Brundage MD, Hayter C, Groome, Davidson JR and Nickel JC. 1997. Patient information in prostate cancer: What is important? American Urological Association Meeting, New Orleans.

Davidson JR, MacLean AW, and Brundage MD. 1998. Sleep disturbance in cancer patients. Sleep 21(3 Supp): 171. Association of Professional Sleep Societies, New Orleans.

Davidson JR, MacLean AW, and Brundage MD. 1998. Sleep disturbance in patients attending a regional cancer centre. J. Clin. Invest. Med. 21(Suppl) Abstract # 464. The Royal College of Physicians and Surgeons of Canada Annual Meeting (CARO), Toronto.

Davidson JR, Waisberg JL, Brundage MD, and MacLean AW. 2001. A sleep therapy program for cancer patients with insomnia. Sleep 24: A382. Abstract # 677.P. Association of Professional Sleep Societies, Chicago.

Davidson JR, Aime A, Ivers H, and Morin CM. 2004. Characteristics of Individuals who seek help for insomnia in a clinical setting versus those who volunteer for a research study. Sleep 27: A265. Abstract #594. Association of Professional Sleep Societies, Philadelphia.

Davidson JR, Feldman-Stewart D, Brennenstuhl S, and Ram S. 2005. Insights from focus groups on how to make nonpharmacologic treatments for insomnia available to people with cancer. Sleep 28: A241. Abstract #717. Association of Professional Sleep Societies, Denver.

updated to June/05

top of page